AMH and ovarian serous adenocarcinoma: One of the most convincing evidence of the anti-tumor activity of AMH is its additive effect on ovarian serous cancer with paclitaxel and cisplatin and its synergistic effect with rapamycin and doxorubicin (28) (Figure 6).